| Literature DB >> 35366843 |
Xingman Guo1, Xiyue Yu2, Qianqian Yao1, Jian Qin3.
Abstract
BACKGROUND: Fragility fracture is one of the most serious consequences of female aging, which can increase the risk of death. Therefore, paying attention to the pathogenesis of postmenopausal osteoporosis (PMOP) is very important for elderly women. METHODS AND MATERIALS: Forty 12-week-old female rats were divided into two groups including the ovariectomy (OVX) group and the control group. Four rats in each group were selected at 1, 4, 8, 12 and 16 weeks after operation. Vertebral bones and femurs were dissected completely for micro-Computed Tomography (micro-CT) scanning, biological modulus detection and histomorphological observation.Entities:
Keywords: Biomechanical properties; Bone metabolic indexes; Bone microstructure; Micro-CT; Ovariectomized rats
Mesh:
Year: 2022 PMID: 35366843 PMCID: PMC8977003 DOI: 10.1186/s12891-022-05265-1
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Three-dimensional reconstruction and cross-sectional images of L5 vertebral bone and left femoral shaft through micro-CT for OVX group rats. A-D Represents the vertebral bone. E-H Represents the femoral shaft. The first and third columns of pictures represent the 1th week and other columns of pictures represent the 16th week in OVX group rats. The region of interest is the volume of bone trabecular within the green line
Weight (g) results of two groups in different periods
| Time | OVX Group ( | Control Group ( | ||
|---|---|---|---|---|
| Weight(g) | 1 week | 273.33 ± 15.27 | 279.67 ± 4.50 | 0.742 |
| 4 weeks | 384.50 ± 26.76 | 317.00 ± 25.91 | <0.001 | |
| 8 weeks | 409.50 ± 15.58 | 332.75 ± 8.65 | <0.001 | |
| 12 weeks | 446.75 ± 22.44 | 353.50 ± 35.40 | <0.001 | |
| 16 weeks | 472.00 ± 29.41 | 361.50 ± 24.40 | <0.001 | |
| <0.001 | 0.004 |
Data are presented as mean ± SD. The body weight of rats in both groups increased significantly (P < 0.05)
Results and comparison of micro-CT microstructure indexes of vertebral bodies between the two groups
| Time | OVX Group ( | Control Group ( | ||
|---|---|---|---|---|
| BV/TV (%) | 1 week | 0.41 ± 0.03 | 0.42 ± 0.08 | 0.628 |
| 4 weeks | 0.34 ± 0.04 | 0.46 ± 0.03 | 0.001 | |
| 8 weeks | 0.34 ± 0.03 | 0.44 ± 0.05 | 0.005 | |
| 12 weeks | 0.30 ± 0.03 | 0.45 ± 0.03 | <0.001 | |
| 16 weeks | 0.30 ± 0.02 | 0.47 ± 0.04 | <0.001 | |
| 0.003 | 0.832 | |||
| Conn.D (1/mm3) | 1 week | 110.90 ± 18.05 | 115.99 ± 16.36 | 0.625 |
| 4 weeks | 90.63 ± 12.66 | 90.87 ± 22.21 | 0.982 | |
| 8 weeks | 96.99 ± 9.13 | 84.43 ± 13.40 | 0.232 | |
| 12 weeks | 73.71 ± 5.41 | 100.08 ± 15.51 | 0.016 | |
| 16 weeks | 67.52 ± 8.99 | 97.93 ± 16.27 | 0.006 | |
| 0.001 | 0.155 | |||
| Tb.N (1/mm) | 1 week | 4.55 ± 0.38 | 4.69 ± 0.36 | 0.586 |
| 4 weeks | 4.23 ± 0.18 | 4.64 ± 0.61 | 0.117 | |
| 8 weeks | 4.39 ± 0.27 | 4.78 ± 0.46 | 0.138 | |
| 12 weeks | 3.88 ± 0.42 | 5.02 ± 0.19 | <0.001 | |
| 16 weeks | 3.69 ± 0.20 | 5.09 ± 0.29 | <0.001 | |
| 0.008 | 0.470 | |||
| Tb.Th (mm) | 1 week | 0.08 ± 0.00 | 0.08 ± 0.01 | 0.452 |
| 4 weeks | 0.08 ± 0.00 | 0.09 ± 0.00 | 0.006 | |
| 8 weeks | 0.07 ± 0.00 | 0.08 ± 0.00 | 0.019 | |
| 12 weeks | 0.07 ± 0.00 | 0.08 ± 0.00 | 0.032 | |
| 16 weeks | 0.07 ± 0.00 | 0.08 ± 0.00 | 0.017 | |
| 0.281 | 0.687 | |||
| Tb.Sp (mm) | 1 week | 0.20 ± 0.02 | 0.19 ± 0.02 | 0.826 |
| 4 weeks | 0.21 ± 0.01 | 0.19 ± 0.03 | 0.204 | |
| 8 weeks | 0.20 ± 0.01 | 0.18 ± 0.01 | 0.251 | |
| 12 weeks | 0.23 ± 0.03 | 0.17 ± 0.00 | <0.001 | |
| 16 weeks | 0.25 ± 0.01 | 0.17 ± 0.01 | <0.001 | |
| 0.018 | 0.339 |
Results and comparison of micro-CT microstructure indexes of femur between the two groups
| Time | OVX Group ( | Control Group ( | ||
|---|---|---|---|---|
| BV/TV (%) | 1 week | 0.12 ± 0.03 | 0.12 ± 0.05 | 0.738 |
| 4 weeks | 0.07 ± 0.02 | 0.16 ± 0.04 | 0.001 | |
| 8 weeks | 0.06 ± 0.01 | 0.18 ± 0.03 | <0.001 | |
| 12 weeks | 0.05 ± 0.01 | 0.13 ± 0.05 | 0.001 | |
| 16 weeks | 0.05 ± 0.01 | 0.13 ± 0.01 | 0.006 | |
| 0.002 | 0.206 | |||
| Conn. D (1/mm3) | 1 week | 49.36 ± 16.36 | 47.14 ± 24.78 | 0.842 |
| 4 weeks | 25.17 ± 8.45 | 76.88 ± 21.43 | <0.001 | |
| 8 weeks | 23.13 ± 7.29 | 63.82 ± 2.21 | 0.001 | |
| 12 weeks | 14.29 ± 6.86 | 51.47 ± 29.70 | 0.002 | |
| 16 weeks | 14.04 ± 1.88 | 48.01 ± 4.16 | 0.004 | |
| 0.001 | 0.216 | |||
| Tb.N (1/mm) | 1 week | 2.74 ± 0.39 | 2.36 ± 0.43 | 0.176 |
| 4 weeks | 1.28 ± 0.19 | 3.29 ± 0.51 | <0.001 | |
| 8 weeks | 0.82 ± 0.21 | 3.09 ± 0.21 | <0.001 | |
| 12 weeks | 0.96 ± 0.24 | 2.56 ± 0.78 | <0.001 | |
| 16 weeks | 1.09 ± 0.17 | 2.59 ± 0.22 | <0.001 | |
| <0.001 | 0.074 | |||
| Tb.Th (mm) | 1 week | 0.06 ± 0.00 | 0.07 ± 0.00 | 0.899 |
| 4 weeks | 0.06 ± 0.01 | 0.06 ± 0.00 | 0.083 | |
| 8 weeks | 0.07 ± 0.00 | 0.07 ± 0.00 | 0.564 | |
| 12 weeks | 0.07 ± 0.00 | 0.07 ± 0.00 | 0.831 | |
| 16 weeks | 0.07 ± 0.00 | 0.06 ± 0.00 | 0.528 | |
| 0.313 | 0.312 | |||
| Tb.Sp (mm) | 1 week | 0.36 ± 0.06 | 0.44 ± 0.09 | 0.492 |
| 4 weeks | 0.81 ± 0.12 | 0.30 ± 0.05 | <0.001 | |
| 8 weeks | 1.31 ± 0.34 | 0.32 ± 0.03 | <0.001 | |
| 12 weeks | 1.10 ± 0.25 | 0.41 ± 0.12 | <0.001 | |
| 16 weeks | 0.97 ± 0.16 | 0.39 ± 0.03 | <0.001 | |
| <0.001 | 0.100 |
Data are presented as mean ± SD
BV/TV The bone volume/total volume, Conn.D Bone trabecular connection density, Tb.N Trabecular bone number, Tb.Th Trabecular bone thickness, Tb.Sp Trabecular bone separation
Results and comparison of elastic modulus (MPa) of vertebral bone and femur between two groups
| Time | OVX Group ( | Control Group ( | ||
|---|---|---|---|---|
| Elastic modulus (MPa) of vertebral body | 1 week | 6.60 ± 0.77 | 5.78 ± 2.85 | 0.769 |
| 4 weeks | 9.88 ± 4.92 | 10.04 ± 1.86 | 0.954 | |
| 8 weeks | 10.17 ± 1.97 | 10.06 ± 1.62 | 0.968 | |
| 12 weeks | 11.11 ± 7.17 | 13.19 ± 3.52 | 0.454 | |
| 16 weeks | 12.12 ± 5.59 | 12.78 ± 3.60 | 0.812 | |
| 0.557 | 0.015 | |||
| Elastic modulus (MPa) of femur | 1 week | 5.22 ± 0.89 | 8.47 ± 1.25 | 0.286 |
| 4 weeks | 14.72 ± 1.75 | 17.00 ± 6.04 | 0.416 | |
| 8 weeks | 12.72 ± 1.79 | 14.72 ± 3.44 | 0.473 | |
| 12 weeks | 14.93 ± 1.94 | 16.79 ± 2.22 | 0.507 | |
| 16 weeks | 16.39 ± 4.52 | 19.30 ± 7.87 | 0.301 | |
| <0.001 | 0.116 |
Data are presented as mean ± SD
Results and comparison of BTMs and inflammatory markers between the two groups
| Time | OVX Group ( | Control Group ( | ||
|---|---|---|---|---|
| TRAP | 1 week | 3.70 ± 0.53 | 3.37 ± 0.24 | 0.702 |
| 4 weeks | 2.99 ± 0.42 | 3.45 ± 0.67 | 0.491 | |
| 8 weeks | 2.86 ± 1.56 | 3.62 ± 1.48 | 0.266 | |
| 12 weeks | 1.87 ± 0.32 | 2.83 ± 1.02 | 0.158 | |
| 16 weeks | 6.52 ± 0.49 | 6.89 ± 0.97 | 0.581 | |
| <0.001 | 0.001 | |||
| CTX-I | 1 week | 0.53 ± 0.14 | 0.72 ± 0.26 | 0.351 |
| 4 weeks | 0.56 ± 0.14 | 0.50 ± 0.17 | 0.744 | |
| 8 weeks | 0.39 ± 0.25 | 0.58 ± 0.36 | 0.243 | |
| 12 weeks | 0.39 ± 0.08 | 0.45 ± 0.20 | 0.721 | |
| 16 weeks | 0.95 ± 0.26 | 0.76 ± 0.23 | 0.237 | |
| 0.011 | 0.441 | |||
| BGP | 1 week | 12.99 ± 1.71 | 12.97 ± 2.24 | 0.996 |
| 4 weeks | 11.01 ± 0.50 | 10.36 ± 2.04 | 0.786 | |
| 8 weeks | 6.20 ± 3.16 | 10.03 ± 3.93 | 0.119 | |
| 12 weeks | 7.50 ± 1.56 | 10.76 ± 6.96 | 0.181 | |
| 16 weeks | 12.19 ± 2.94 | 11.39 ± 2.89 | 0.738 | |
| 0.007 | 0.939 | |||
| PINP | 1 week | 11.90 ± 1.15 | 13.57 ± 5.12 | 0.554 |
| 4 weeks | 9.64 ± 1.30 | 8.22 ± 2.57 | 0.518 | |
| 8 weeks | 6.11 ± 3.66 | 8.84 ± 5.02 | 0.218 | |
| 12 weeks | 6.96 ± 1.84 | 8.89 ± 3.40 | 0.379 | |
| 16 weeks | 14.88 ± 2.01 | 13.35 ± 2.92 | 0.488 | |
| 0.001 | 0.222 | |||
| IL-6 | 1 week | 12.79 ± 1.08 | 13.66 ± 4.30 | 0.881 |
| 4 weeks | 11.93 ± 1.76 | 12.76 ± 1.27 | 0.853 | |
| 8 weeks | 11.65 ± 1.30 | 10.86 ± 2.90 | 0.863 | |
| 12 weeks | 13.21 ± 2.37 | 13.35 ± 3.57 | 0.977 | |
| 16 weeks | 23.17 ± 17.06 | 14.35 ± 5.39 | 0.059 | |
| 0.284 | 0.734 | |||
| TNF-α | 1 week | 24.61 ± 3.57 | 28.02 ± 7.60 | 0.725 |
| 4 weeks | 25.72 ± 3.65 | 24.76 ± 2.83 | 0.898 | |
| 8 weeks | 24.17 ± 2.47 | 22.61 ± 5.92 | 0.835 | |
| 12 weeks | 25.42 ± 2.54 | 24.67 ± 5.63 | 0.920 | |
| 16 weeks | 45.59 ± 28.06 | 28.41 ± 8.60 | 0.011 | |
| 0.172 | 0.704 |
Data are presented as mean ± SD
TRAP The tartrate resistant acid phosphatase, CTX-I Type I collagen carboxy terminal peptide, BGP Osteocalcin, PINP Type I procollagen amino terminal propeptide, IL-6 Interleukin-6, TNF-α Tumor necrosis factor-α
Fig. 2HE staining of OVX group. A-D The 1th week of L5 vertebral bone, the 16th week of L5 vertebral bone, the 1th week and the 16th week of left femoral head HE image (HE; magnification, 20X). The micrographs of OVX rats showed a typical osteopenia with loss of trabecular bone numbers and interconnectivity with time (arrow heads)